Lexaria Bioscience Statistics
Total Valuation
LEXX has a market cap or net worth of $14.93 million. The enterprise value is $9.76 million.
Important Dates
The last earnings date was Monday, April 13, 2026.
| Earnings Date | Apr 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LEXX has 24.79 million shares outstanding. The number of shares has increased by 31.30% in one year.
| Current Share Class | 24.79M |
| Shares Outstanding | 24.79M |
| Shares Change (YoY) | +31.30% |
| Shares Change (QoQ) | +14.35% |
| Owned by Insiders (%) | 4.09% |
| Owned by Institutions (%) | 6.62% |
| Float | 23.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 40.58 |
| Forward PS | n/a |
| PB Ratio | 2.27 |
| P/TBV Ratio | 2.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 26.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 26.88, with a Debt / Equity ratio of 0.02.
| Current Ratio | 26.88 |
| Quick Ratio | 24.74 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -147.07% and return on invested capital (ROIC) is -87.36%.
| Return on Equity (ROE) | -147.07% |
| Return on Assets (ROA) | -75.97% |
| Return on Invested Capital (ROIC) | -87.36% |
| Return on Capital Employed (ROCE) | -146.94% |
| Weighted Average Cost of Capital (WACC) | 6.22% |
| Revenue Per Employee | $52,571 |
| Profits Per Employee | -$1.36M |
| Employee Count | 7 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LEXX has paid $4,389 in taxes.
| Income Tax | 4,389 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.96% in the last 52 weeks. The beta is 0.36, so LEXX's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -43.96% |
| 50-Day Moving Average | 0.81 |
| 200-Day Moving Average | 0.88 |
| Relative Strength Index (RSI) | 33.53 |
| Average Volume (20 Days) | 209,707 |
Short Selling Information
The latest short interest is 382,904, so 1.54% of the outstanding shares have been sold short.
| Short Interest | 382,904 |
| Short Previous Month | 283,017 |
| Short % of Shares Out | 1.54% |
| Short % of Float | 1.63% |
| Short Ratio (days to cover) | 1.98 |
Income Statement
In the last 12 months, LEXX had revenue of $368,000 and -$9.53 million in losses. Loss per share was -$0.46.
| Revenue | 368,000 |
| Gross Profit | 368,000 |
| Operating Income | -9.22M |
| Pretax Income | -9.53M |
| Net Income | -9.53M |
| EBITDA | -9.13M |
| EBIT | -9.22M |
| Loss Per Share | -$0.46 |
Full Income StatementBalance Sheet
The company has $5.27 million in cash and $94,386 in debt, with a net cash position of $5.18 million or $0.21 per share.
| Cash & Cash Equivalents | 5.27M |
| Total Debt | 94,386 |
| Net Cash | 5.18M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 6.21M |
| Book Value Per Share | 0.27 |
| Working Capital | 5.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.37 million and capital expenditures -$40,816, giving a free cash flow of -$9.42 million.
| Operating Cash Flow | -9.37M |
| Capital Expenditures | -40,816 |
| Depreciation & Amortization | 88,320 |
| Net Borrowing | n/a |
| Free Cash Flow | -9.42M |
| FCF Per Share | -$0.38 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -2,504.67% |
| Pretax Margin | -2,590.67% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LEXX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.30% |
| Shareholder Yield | -31.30% |
| Earnings Yield | -63.82% |
| FCF Yield | -63.05% |
Analyst Forecast
The average price target for LEXX is $1.50, which is 149.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.50 |
| Price Target Difference | 149.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 128.75% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 12, 2021. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jan 12, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
LEXX has an Altman Z-Score of 26.93 and a Piotroski F-Score of 3.
| Altman Z-Score | 26.93 |
| Piotroski F-Score | 3 |
